title: A novel potent strategy for gene delivery using a single peptide vector as a carrier.
abstract: We have shown previously that a peptide, MPG, derived from the hydrophobic fusion peptide of HIV-1 gp41 and the hydrophilic nuclear localisation sequence of SV40 large T antigen, can be used as a powerful tool for the delivery of oligonucleotides into cultured cells. Now we extend the potential of MPG to the delivery of nucleic acids into cultured cells. In vitro, MPG interacts strongly with nucleic acids, most likely forming a peptide cage around them, which stabilises and protects them from degradation in cell culture media. MPG is non-cytotoxic, insensitive to serum and efficiently delivers plasmids into several different cell lines in only 1 h. Moreover, MPG enables complete expression of the gene products encoded by the plasmids it delivers into cultured cells. Finally, we have investigated the potential of MPG as an efficient delivery agent for gene therapy, by attempting to deliver antisense nucleic acids targeting an essential cell cycle gene. MPG efficiently delivered a plasmid expressing the full-length antisense cDNA of human cdc25C, which consequently successfully reduced cdc25C expression levels and promoted a block to cell cycle progression. Based on our results, we conclude that MPG is a potent delivery agent for the generalised delivery of nucleic acids as well as of oligonucleotides into cultured cells and believe that its contribution to the development of new gene therapy strategies could be of prime interest.
authors.affiliation: Centre de Recherches de Biochimie Macromoleculaire, UPR-1086 CNRS, 1919 Route de Mende, 34293 Montpellier Cedex 5, France.
authors.forename: M C
authors.initials: MC
authors.lastname: Morris
authors.forename: L
authors.initials: L
authors.lastname: Chaloin
authors.forename: J
authors.initials: J
authors.lastname: Méry
authors.forename: F
authors.initials: F
authors.lastname: Heitz
authors.forename: G
authors.initials: G
authors.lastname: Divita
mesh_terms: D016475:3T3 Cells; D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000235:genetics; D019556:COS Cells; D002453:Cell Cycle / Q000187:drug effects; D018797:Cell Cycle Proteins / Q000235:genetics; D002460:Cell Line; D016373:DNA, Antisense / Q000235:genetics / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005347:Fibroblasts / Q000378:metabolism; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D015700:HIV Envelope Protein gp41 / Q000235:genetics; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D051379:Mice; D009841:Oligonucleotides / Q000235:genetics* / Q000378:metabolism; D010452:Peptide Biosynthesis; D010455:Peptides / Q000235:genetics*; D010749:Phosphoprotein Phosphatases / Q000235:genetics; D010957:Plasmids / Q000378:metabolism; D020687:cdc25 Phosphatases
chemical_list: D000952:Antigens, Polyomavirus Transforming; D018797:Cell Cycle Proteins; D016373:DNA, Antisense; D015700:HIV Envelope Protein gp41; D009841:Oligonucleotides; D010455:Peptides; D008156:Luciferases; D010749:Phosphoprotein Phosphatases; C517009:CDC25C protein, human; C517010:Cdc25c protein, mouse; D020687:cdc25 Phosphatases